The FDA issued a warning letter to Novo Nordisk for failing to report serious adverse events linked to Ozempic, Wegovy, and Saxenda. Investigators cited systemic failures in reporting strokes, suicides, and deaths.
April 5, 2026
The FDA issued a warning letter to Novo Nordisk for failing to report serious adverse events linked to Ozempic, Wegovy, and Saxenda. Investigators cited systemic failures in reporting strokes, suicides, and deaths.